Cargando…

Evaluation of Different Breast Cancer Screening Strategies for High-Risk Women in Beijing, China: A Real-World Population-Based Study

BACKGROUND: Mammography-based breast cancer screening has been widely implemented in many developed countries. Evidence was needed on participation and diagnostic performance of population-based breast cancer screening using ultrasound in China. METHODS: We used data from the Cancer Screening Progra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xi, Yang, Lei, Liu, Shuo, Li, Huichao, Li, Qingyu, Cheng, Yangyang, Wang, Ning, Ji, Jiafu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600225/ https://www.ncbi.nlm.nih.gov/pubmed/34804981 http://dx.doi.org/10.3389/fonc.2021.776848

Ejemplares similares

Performance of different colorectal cancer screening strategies: a long-term passive follow-up population-based screening program in Beijing, China
por: Zhang, Xi, et al.
Publicado: (2023)

Epidemiological Characteristics of Peripheral T-Cell Lymphoma: A Population-Based Study
por: Liu, Shuo, et al.
Publicado: (2022)

Secular trends in incidence of lung cancer by histological type in Beijing, China, 2000−2016
por: Yang, Lei, et al.
Publicado: (2019)

Effects of insurance status on long-term survival among non-small cell lung cancer (NSCLC) patients in Beijing, China: A population-based study
por: Wang, Zheng, et al.
Publicado: (2020)

Gastric cancer: Epidemiology, risk factors and prevention strategies
por: Yang, Lei, et al.
Publicado: (2020)

Cost-effectiveness of precision screening for esophageal cancer based on individualized risk stratification in China: Real-world evidence from the ESECC trial
por: Li, Fuxiao, et al.
Publicado: (2022)

What predicts the clinical benefits of PARP inhibitors in platinum-sensitive recurrent ovarian cancer: A real-world single-center retrospective cohort study from China
por: Zhang, Depu, et al.
Publicado: (2022)

Efficacy and Safety of Lenvatinib Combined With PD-1 Inhibitors Plus TACE for Unresectable Hepatocellular Carcinoma Patients in China Real-World
por: Li, Xiaowei, et al.
Publicado: (2022)

Multi-Modality Treatment for Patients With Metastatic Gastric Cancer: A Real-World Study in China
por: Zhao, Lin, et al.
Publicado: (2019)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

The characteristics of overseas imported COVID-19 cases and the effectiveness of screening strategies in Beijing, China
por: Li, Li, et al.
Publicado: (2022)

Basic epidemiological parameter values from data of real-world in mega-cities: the characteristics of COVID-19 in Beijing, China
por: Wang, Xiaoli, et al.
Publicado: (2020)

Real-World Data of Different Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer in China
por: Miao, Kang, et al.
Publicado: (2022)

Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China
por: Gao, Fenghua, et al.
Publicado: (2022)

Real-world assessment of attenuated dosing anti-PD1 therapy as an alternative dosing strategy in a high-income country (as defined by World Bank)
por: Low, Jia Li, et al.
Publicado: (2022)

The Clinical Characteristics and Prognosis of AYA and Older Adult ETP-ALL/LBL: A Real-World Multicenter Study in China
por: Xiao, Jinyan, et al.
Publicado: (2022)

Characteristics and prognostic values of traditional pathological parameters and advanced molecular subtypes in women in Beijing with operable breast cancer: a retrospective analysis
por: Li, Qin, et al.
Publicado: (2018)

A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China
por: Liu, Weiping, et al.
Publicado: (2021)

Efficacy and safety of camrelizumab plus transarterial chemoembolization in intermediate to advanced hepatocellular carcinoma patients: A prospective, multi-center, real-world study
por: You, Ran, et al.
Publicado: (2022)

Pyrotinib in the Treatment of Women With HER2-Positive Advanced Breast Cancer: A Multicenter, Prospective, Real-World Study
por: Zhang, Lili, et al.
Publicado: (2021)

Rubella seroprevalence among pregnant women in Beijing, China
por: Meng, Qinghong, et al.
Publicado: (2018)

Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes
por: Cheeseman, Sue, et al.
Publicado: (2023)

Pediatric non–Down’s syndrome acute megakaryoblastic leukemia patients in China: A single center's real-world analysis
por: Zhang, Aoli, et al.
Publicado: (2022)

Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China
por: Yang, Wenyu, et al.
Publicado: (2023)

Ultrasound for Breast Cancer Screening in High-Risk Women: Results From a Population-Based Cancer Screening Program in China
por: Wang, Yong, et al.
Publicado: (2019)

Chemotherapy Decision-Making and Survival Outcomes in Older Women With Early Triple-Negative Breast Cancer: Evidence From Real-World Practice
por: Xiu, Meng, et al.
Publicado: (2022)

Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer: a real-world retrospective study in China
por: Liu, Xiaoyu, et al.
Publicado: (2023)

Effectiveness of TKI Inhibitors Combined With PD-1 in Patients With Postoperative Early Recurrence of HCC: A Real-World Study
por: Li, Zixiong, et al.
Publicado: (2022)

Efficacy of immunotherapy in KRAS-mutant advanced NSCLC: A real-world study in a Chinese population
por: Peng, Lixiu, et al.
Publicado: (2023)

Characteristics and comparison of colorectal cancer incidence in Beijing with other regions in the world
por: Li, Zhongmin, et al.
Publicado: (2017)

Strategies to eliminate cervical cancer in China
por: Ji, Lu, et al.
Publicado: (2023)

Factors associated with breast cancer screening participation among women in mainland China: a systematic review
por: Wu, Zijing, et al.
Publicado: (2019)

Real-World First-Line Treatment Patterns and Outcomes in Hormone Receptor-Positive Advanced Breast Cancer Patients: A Multicenter, Retrospective Study in China
por: Chen, Zhanhong, et al.
Publicado: (2022)

Effectiveness and safety of pembrolizumab for patients with advanced non-small cell lung cancer in real-world studies and randomized controlled trials: A systematic review and meta-analysis
por: Yang, Beibei, et al.
Publicado: (2023)

Comparative evaluation of novel screening strategies for colorectal cancer screening in China (TARGET-C): a study protocol for a multicentre randomised controlled trial
por: Chen, Hongda, et al.
Publicado: (2019)

A Novel Prognostic Scoring System of Intrahepatic Cholangiocarcinoma With Machine Learning Basing on Real-World Data
por: Li, Zhizhen, et al.
Publicado: (2021)

Surveillance Strategy for Patients With BCLC Stage B Hepatocellular Carcinoma After Achieving Complete Remission: Data From the Real World
por: Wu, Ying, et al.
Publicado: (2020)

Efficacy of intra-arterial chemotherapy with sequential anti-PD-1 antibody in unresectable gastric cancer: A retrospective real-world study
por: Xiang, Xiaosong, et al.
Publicado: (2023)

Survival analysis of patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment of Yunnan in southwestern China: a real-world study
por: Lin, Yanping, et al.
Publicado: (2023)

Editorial: Real World Outcomes of Lymphoma From India
por: Kumar, Lalit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_put6lg4mbuul1ak0ks9b7e8fkf